$CYCU

Cycurion Q2 Results: EPS beats estimate, sales miss YoY growth

Cycurion (NASDAQ: CYCU) reported Q2 EPS of $(0.41), beating the $(0.56) consensus, and Q2 revenue of $3.757 million, above the $3.615 million estimate. However, sales fell 3.37% year over year to $3.888 million. The company also said its Nasdaq delisting hearing is set for Aug. 20, 2026.

Original reporting
Published Aug 14, 2026, 2:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 15, 2026, 1:19 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cycurion Q2 Results: EPS beats estimate, sales miss YoY growth — source image
Decision brief

The 30-second read

$CYCUNeutralMed
01

Why it matters

The quarter shows a sharp EPS loss narrowing alongside modest revenue contraction, while the Nasdaq hearing date keeps a binary delisting risk in focus until the Panel’s final written decision.

02

Market read

Traders get two actionable catalysts: a Q2 EPS beat with YoY revenue decline, and a confirmed Aug 20 Nasdaq hearing that can affect delisting risk and trading liquidity.

03

What to watch

The Nasdaq hearing is a separate catalyst; traders may price in delisting probability and liquidity risk more than the quarter’s operating performance.

Relevance 7/10Novelty 6/10Timing: ahead of Aug 20 Nasdaq Hearings Panel decision

Background

Cycurion is a Nasdaq-listed cybersecurity provider facing an exchange compliance review, with a scheduled hearing before the Nasdaq Hearings Panel on Aug 20, 2026.

Company-level read

Ticker impact

$CYCUNeutralMedium confidence
Context

Cycurion reported Q2 EPS of -$0.41, beating -$0.56 consensus, while sales fell 3.37% YoY to $3.757M.

Expected impact

Near-term volatility likely around earnings interpretation and the upcoming Nasdaq Hearings Panel timeline.

Evidence & confidence

The article provides concrete Q2 EPS and sales figures plus a scheduled Nasdaq hearing date, both of which can drive trading decisions. However, it lacks guidance, cash flow, and delisting outcome details, limiting conviction on magnitude/direction.

Market effects

Cybersecurity small-cap sentiment may hinge on whether cost discipline can offset weak top-line trends.

No clear regional spillover beyond US small-cap tech risk appetite.

Limited, as the news is company-specific (earnings plus Nasdaq compliance process).

Counterpoint

The EPS beat could be driven by one-time items or non-recurring expense reductions, so the market may fade the improvement if revenue weakness persists.

Key entities

  • Cycurion

    NASDAQ-listed cybersecurity solutions provider reporting Q2 results and confirming an Aug 20 Nasdaq Hearings Panel hearing.

  • Nasdaq Hearings Panel

    Exchange body scheduled to issue a final written decision after the Aug 20 hearing.

  • Kevin Kelly

    Chairman and CEO who reiterated focus on the business plan and the Nasdaq process.

Related articles

$CYCUMedAI 8/10

Cycurion Closes Acquisition of Kustom Entertainment’s Legacy Video Solutions Business, Expanding Public Safety Technology Portfolio

Cycurion, Inc. (NASDAQ: CYCU) said it has closed its acquisition of substantially all assets of Kustom Entertainment’s (NASDAQ: KUST) legacy video solutions business. The deal adds Digital Ally-branded video and evidence offerings, over 50 patents, and is expected to contribute more than $5M in annual revenue and over $1.2M in EBITDA at closing, plus access to 800+ public safety clients.

$CYCUMedAI 8/10

Cycurion Gains Access to More Than 800 Public Safety Clients

Cycurion (NASDAQ: CYCU) said it has closed its acquisition of substantially all assets of Kustom Entertainment’s (NASDAQ: KUST) legacy Digital Ally video solutions business. Cycurion expects the deal to add more than $5M in annual revenue and over $1.2M in EBITDA, lifting pro forma gross revenue run rate to about $30M, and to give access to 800+ public safety clients and 50+ patents.